Cargando…
Immunoexperssion of cancer stem cell marker (CD44) in ameloblastoma
BACKGROUND: Ameloblastoma is the most frequently encountered benign, locally invasive tumor. Attempts to surgically resect the tumor often leave small islands of tumor, which later result in recurrence in 50%–90% of cases. This has raised questions regarding the tumor cell populations that are respo...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948039/ https://www.ncbi.nlm.nih.gov/pubmed/31942121 http://dx.doi.org/10.4103/jomfp.JOMFP_152_17 |
_version_ | 1783485677424345088 |
---|---|
author | Vanje, Manjushri Madhukar Tanveer, Shahela Ahmed, Syed Afroz Kumar, Shravan Vanje, Tejashree |
author_facet | Vanje, Manjushri Madhukar Tanveer, Shahela Ahmed, Syed Afroz Kumar, Shravan Vanje, Tejashree |
author_sort | Vanje, Manjushri Madhukar |
collection | PubMed |
description | BACKGROUND: Ameloblastoma is the most frequently encountered benign, locally invasive tumor. Attempts to surgically resect the tumor often leave small islands of tumor, which later result in recurrence in 50%–90% of cases. This has raised questions regarding the tumor cell populations that are responsible for tumor growth and recurrence. In ameloblastoma, whether or not cancer stem-like cells are present remains undetermined. However, if cancer stem-like cells are present in ameloblastoma, it is important to identify which type of cell possesses the stem-like characteristics and is responsible for ameloblastoma progression and recurrence. AIM: Our study aims at analyzing immunohistochemical staining to detect the expression of cancer stem cell (CSC) marker CD44 in relation to proliferative activity of tumor cells in histopathologically diagnosed cases of ameloblastoma variants and to derive a correlation between the CD44 expression and biologic behavior of the lesion. MATERIALS AND METHODS: A retrospective study, was conducted on total 25 cases ameloblastoma and were immunostained for CD44 expression. Results obtained were statistically analyzed. RESULTS: A positive correlation was observed between staining intensity of CD44 marker and the known biological behavior of the lesion. Intense staining reaction was found to be only in 8% cases, whereas 76% cases demonstrated moderate intensity and remaining 16% displayed mild immunoreactivity to CD44 marker. Staining location was more to be in stellate reticulum-like (SR-like) cells when compared to ameloblast-like (AB-like) cells. Intense immunostaining was localized in the small tumor follicles, especially in SR-like cells situated in close vicinity of peripheral AB-like cells whereas mild intensity of staining was observed in keratinizing areas. CONCLUSION: CSCs marker positive expression in benign tumor like ameloblastoma may be responsible for its aggressiveness and recurrence. CD44 marker may be of great value in predicting the biological behavior and growth potential of ameloblastoma. |
format | Online Article Text |
id | pubmed-6948039 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-69480392020-01-15 Immunoexperssion of cancer stem cell marker (CD44) in ameloblastoma Vanje, Manjushri Madhukar Tanveer, Shahela Ahmed, Syed Afroz Kumar, Shravan Vanje, Tejashree J Oral Maxillofac Pathol Original Article BACKGROUND: Ameloblastoma is the most frequently encountered benign, locally invasive tumor. Attempts to surgically resect the tumor often leave small islands of tumor, which later result in recurrence in 50%–90% of cases. This has raised questions regarding the tumor cell populations that are responsible for tumor growth and recurrence. In ameloblastoma, whether or not cancer stem-like cells are present remains undetermined. However, if cancer stem-like cells are present in ameloblastoma, it is important to identify which type of cell possesses the stem-like characteristics and is responsible for ameloblastoma progression and recurrence. AIM: Our study aims at analyzing immunohistochemical staining to detect the expression of cancer stem cell (CSC) marker CD44 in relation to proliferative activity of tumor cells in histopathologically diagnosed cases of ameloblastoma variants and to derive a correlation between the CD44 expression and biologic behavior of the lesion. MATERIALS AND METHODS: A retrospective study, was conducted on total 25 cases ameloblastoma and were immunostained for CD44 expression. Results obtained were statistically analyzed. RESULTS: A positive correlation was observed between staining intensity of CD44 marker and the known biological behavior of the lesion. Intense staining reaction was found to be only in 8% cases, whereas 76% cases demonstrated moderate intensity and remaining 16% displayed mild immunoreactivity to CD44 marker. Staining location was more to be in stellate reticulum-like (SR-like) cells when compared to ameloblast-like (AB-like) cells. Intense immunostaining was localized in the small tumor follicles, especially in SR-like cells situated in close vicinity of peripheral AB-like cells whereas mild intensity of staining was observed in keratinizing areas. CONCLUSION: CSCs marker positive expression in benign tumor like ameloblastoma may be responsible for its aggressiveness and recurrence. CD44 marker may be of great value in predicting the biological behavior and growth potential of ameloblastoma. Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6948039/ /pubmed/31942121 http://dx.doi.org/10.4103/jomfp.JOMFP_152_17 Text en Copyright: © 2019 Journal of Oral and Maxillofacial Pathology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Vanje, Manjushri Madhukar Tanveer, Shahela Ahmed, Syed Afroz Kumar, Shravan Vanje, Tejashree Immunoexperssion of cancer stem cell marker (CD44) in ameloblastoma |
title | Immunoexperssion of cancer stem cell marker (CD44) in ameloblastoma |
title_full | Immunoexperssion of cancer stem cell marker (CD44) in ameloblastoma |
title_fullStr | Immunoexperssion of cancer stem cell marker (CD44) in ameloblastoma |
title_full_unstemmed | Immunoexperssion of cancer stem cell marker (CD44) in ameloblastoma |
title_short | Immunoexperssion of cancer stem cell marker (CD44) in ameloblastoma |
title_sort | immunoexperssion of cancer stem cell marker (cd44) in ameloblastoma |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948039/ https://www.ncbi.nlm.nih.gov/pubmed/31942121 http://dx.doi.org/10.4103/jomfp.JOMFP_152_17 |
work_keys_str_mv | AT vanjemanjushrimadhukar immunoexperssionofcancerstemcellmarkercd44inameloblastoma AT tanveershahela immunoexperssionofcancerstemcellmarkercd44inameloblastoma AT ahmedsyedafroz immunoexperssionofcancerstemcellmarkercd44inameloblastoma AT kumarshravan immunoexperssionofcancerstemcellmarkercd44inameloblastoma AT vanjetejashree immunoexperssionofcancerstemcellmarkercd44inameloblastoma |